Eptazocine

Eptazocine.svg

Eptazocine is a synthetic opioid analgesic that is used for the management of moderate to severe pain. It is a member of the benzomorphan class of opioids and exhibits both agonist and antagonist properties at opioid receptors.

Pharmacology

Eptazocine acts primarily on the mu (μ) and kappa (κ) opioid receptors. It has a mixed agonist-antagonist profile, meaning it can activate certain opioid receptors while blocking others. This dual action helps in providing pain relief while potentially reducing the risk of addiction and overdose.

Medical Uses

Eptazocine is primarily indicated for the treatment of moderate to severe pain. It is often used in situations where other pain management strategies are ineffective or contraindicated. Due to its mixed agonist-antagonist properties, it may be preferred in patients with a history of substance abuse.

Side Effects

Common side effects of eptazocine include:

• Nausea
• Vomiting
• Dizziness
• Sedation
• Constipation

Serious side effects may include:

• Respiratory depression
• Hypotension
• Allergic reactions

Contraindications

Eptazocine should not be used in patients with:

• Known hypersensitivity to eptazocine or any of its components
• Severe respiratory depression
• Acute or severe bronchial asthma
• Paralytic ileus

Interactions

Eptazocine may interact with other central nervous system depressants, such as:

• Alcohol
• Benzodiazepines
• Other opioids

These interactions can increase the risk of respiratory depression, sedation, and hypotension.

Regulation

Eptazocine is classified as a controlled substance in many countries due to its potential for abuse and dependence. The specific scheduling and regulatory controls may vary by jurisdiction.

See Also

• Opioid
• Analgesic
• Pain management
• Opioid receptor

External Links

‎